Aydın Hamide, Üstün Burcu, Şahintürk Utkan, Değirmenci Nurdan Sena, Şahin Fikrettin, Kaptan Usul Sedef, Aslan Ayşe, Demir Muslum, Kurtan Ümran
Department of Chemistry, İstanbul University-Cerrahpaşa, Istanbul 34500, Türkiye.
Materials Institute, The Scientific and Technological Research Council of Türkiye (TUBITAK) - Marmara Research Center (MAM), Gebze 41470, Türkiye.
ACS Appl Bio Mater. 2025 Aug 18;8(8):6745-6754. doi: 10.1021/acsabm.5c00161. Epub 2025 Jul 14.
Herein, nanocrystalline MoB powder synthesized via a single-step molten salt reaction of precursor materials MoCl and amorphous boron powder in the presence of KCl and NaCl by varying the boron amount was applied for the first time in vitro cytotoxicity and antibacterial studies. The crystalline structure, morphology, and surface characteristics were investigated in detail by powder X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), high-resolution transmission electron microscopy (HRTEM), and Brunauer-Emmett-Teller (BET) analysis. The results indicated that the amount of boron played a crucial role in the nanostructure of MoB. XRD results showed an enhancement in crystallinity, and HRTEM examinations revealed a rise in reflections (100) and growth in grains with the rise in boron amount during the synthesis of MoB. The particle size was found to be in the range of 50-100 nm, and the surface areas of MoB nanoparticles were measured between 7.74 and 16.11 m/g. In vitro findings showed that MoB-16 did not have a significant cytotoxic effect on healthy cells (HaCaT and MCF10A), but it exhibited a notable cytotoxic effect on breast cancer cell lines (MDA-MB-231 and MCF7 cells), whereas no cytotoxic effect occurred on the liver cancer line Hep3B cells. Antibacterial studies revealed that MoB-4 exhibited promising antibacterial activity against both and , where MICs were in the range of 60 to 70 μg/mL. Overall, our research reported the successful synthesis and characterization of MoB nanoparticles, which can be efficient anticancer and antibacterial agents.
在此,通过前驱体材料MoCl与无定形硼粉在KCl和NaCl存在下进行单步熔盐反应,通过改变硼的用量合成了纳米晶MoB粉末,并首次将其应用于体外细胞毒性和抗菌研究。通过粉末X射线衍射(XRD)、X射线光电子能谱(XPS)、扫描电子显微镜(SEM)、高分辨率透射电子显微镜(HRTEM)和布鲁诺尔-埃米特-泰勒(BET)分析详细研究了晶体结构、形态和表面特性。结果表明,硼的用量对MoB的纳米结构起着关键作用。XRD结果显示结晶度增强,HRTEM检查表明在MoB合成过程中,随着硼用量的增加,(100)晶面反射增强且晶粒生长。发现粒径在50-100nm范围内,MoB纳米颗粒的表面积在7.74至16.11m²/g之间。体外研究结果表明,MoB-16对健康细胞(HaCaT和MCF10A)没有显著的细胞毒性作用,但对乳腺癌细胞系(MDA-MB-231和MCF7细胞)表现出显著的细胞毒性作用,而对肝癌细胞系Hep3B细胞没有细胞毒性作用。抗菌研究表明,MoB-4对大肠杆菌和金黄色葡萄球菌均表现出有前景的抗菌活性,其最低抑菌浓度(MIC)在60至70μg/mL范围内。总体而言,我们的研究报道了MoB纳米颗粒的成功合成与表征,其可成为高效的抗癌和抗菌剂。